These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18627219)

  • 1. RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potency.
    Huang B; Mao CP; Peng S; Hung CF; Wu TC
    Hum Gene Ther; 2008 Aug; 19(8):763-73. PubMed ID: 18627219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life and intracellular targeting strategies with a strategy to boost CD4+ T cell.
    Kim D; Hoory T; Wu TC; Hung CF
    Hum Gene Ther; 2007 Nov; 18(11):1129-39. PubMed ID: 17939748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.
    Chen CA; Chang MC; Sun WZ; Chen YL; Chiang YC; Hsieh CY; Chen SM; Hsiao PN; Cheng WF
    Gene Ther; 2009 Jun; 16(6):776-87. PubMed ID: 19357714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects.
    Peng S; Trimble C; Alvarez RD; Huh WK; Lin Z; Monie A; Hung CF; Wu TC
    Gene Ther; 2008 Aug; 15(16):1156-66. PubMed ID: 18401437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity.
    Lin CT; Tsai YC; He L; Yeh CN; Chang TC; Soong YK; Monie A; Hung CF; Lai CH
    Immunol Lett; 2007 Dec; 114(2):86-93. PubMed ID: 17976741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination.
    Lee SY; Huang Z; Kang TH; Soong RS; Knoff J; Axenfeld E; Wang C; Alvarez RD; Chen CS; Hung CF; Wu TC
    J Mol Med (Berl); 2013 Oct; 91(10):1221-31. PubMed ID: 23715898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency.
    Wang ST; Chang CC; Yen MC; Tu CF; Chu CL; Peng YT; Chen DY; Lan JL; Lin CC
    Gene Ther; 2011 Apr; 18(4):372-83. PubMed ID: 21107437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand.
    Hung CF; Hsu KF; Cheng WF; Chai CY; He L; Ling M; Wu TC
    Cancer Res; 2001 Feb; 61(3):1080-8. PubMed ID: 11221836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors.
    Diniz MO; Cariri FA; Aps LR; Ferreira LC
    Hum Gene Ther; 2013 Oct; 24(10):861-70. PubMed ID: 24007495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun.
    Kim D; Hoory T; Monie A; Ting JP; Hung CF; Wu TC
    J Immunol; 2008 May; 180(10):7019-27. PubMed ID: 18453624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
    Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].
    Wang QY; Xu YF; Fan DS; Peng QL; Zhang T; Xu XM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):584-91. PubMed ID: 18051710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine.
    Lin CT; Yen CF; Shaw SW; Yen TC; Chen YJ; Soong YK; Lai CH
    Vaccine; 2009 Dec; 27(52):7352-8. PubMed ID: 19781679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.
    Kang TH; Chung JY; Monie A; Pai SI; Hung CF; Wu TC
    Gene Ther; 2010 Apr; 17(4):531-40. PubMed ID: 19940864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with a DNA vaccine encoding herpes simplex virus type 1 VP22 linked to antigen generates long-term antigen-specific CD8-positive memory T cells and protective immunity.
    Kim TW; Hung CF; Kim JW; Juang J; Chen PJ; He L; Boyd DA; Wu TC
    Hum Gene Ther; 2004 Feb; 15(2):167-77. PubMed ID: 14975189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe.
    Trimble C; Lin CT; Hung CF; Pai S; Juang J; He L; Gillison M; Pardoll D; Wu L; Wu TC
    Vaccine; 2003 Sep; 21(25-26):4036-42. PubMed ID: 12922140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells.
    Kim D; Hung CF; Wu TC; Park YM
    Vaccine; 2010 Oct; 28(45):7297-305. PubMed ID: 20817010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments.
    Cheng WF; Hung CF; Hsu KF; Chai CY; He L; Ling M; Slater LA; Roden RB; Wu TC
    Hum Gene Ther; 2001 Feb; 12(3):235-52. PubMed ID: 11177561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer.
    Wu A; Zeng Q; Kang TH; Peng S; Roosinovich E; Pai SI; Hung CF
    Gene Ther; 2011 Mar; 18(3):304-12. PubMed ID: 20981112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies.
    Kim TW; Hung CF; Boyd D; Juang J; He L; Kim JW; Hardwick JM; Wu TC
    J Immunol; 2003 Sep; 171(6):2970-6. PubMed ID: 12960321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.